| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Journal of Korean Neurosurgical Society > Volume 67(4); 2024 > Article
Yang: Editors’ Pick in July 2024
Among the 10 papers published in the July issue of Journal of Korean Neurosurgical Society (JKNS) 2024, the following two papers, which deserve attention from readers, are selected by the editorial boards.

Protein requirement changes according to the treatment application in neurocritical patients [4]

Precise assessment of protein requirements for critically ill patients and appropriate supplementation has become of utmost concern to prevent various complications and improve functional outcomes. In this respect, current nutritional guidelines recommend adequate amounts of protein for critical patients, apart from appropriate calorie suggestions, between 1.2 and 2 g/kg body weight per day [1]. However, this guideline has the disadvantage of not providing accurate dosage requirements and not being able to inform the requirements that vary depending on the stage and condition of critically ill patient. In order to overcome these shortcomings, this study identified the changes in protein requirements during neurocritical treatment, which included coma therapy and therapeutic temperature management (TTM).
The protein requirements were analyzed using urine urea nitrogen (UUN) measurements. The entire treatment period was divided into two phases : phase 1, defined as the period from initiation of coma therapy and TTM until just before tapering and phase 2, defined as the period from the start of tapering until the discontinuation of coma therapy and TTM.
Out of the total 214 UUN data collected from 107 patients, the mean value of protein requirements was 1.84±0.62 g/kg/day. During phase 1, the protein requirement was 1.49±0.42 g/kg/day, while in phase 2, as the treatment was tapered, it increased to 2.18±0.60 g/kg/day. This increase demonstrates statistical significance.
According to the result of the study, which showed a significant increase in protein requirements between phases 1 and 2, it is stressed to monitor protein requirements at each treatment phase rather than at regular intervals. It is also important to be keep in mind that while the overall caloric demand diminishes due to the effects of interventions such as coma therapy and TTM, the protein requirement during phase 1 remains notably high.
The study shows the importance of monitoring protein requirements during the care of neurocritically ill patients, rather than clinging to ‘standardized’ guidelines, to improve the quality of care for better outcomes.

A potential risk of radiation-induced cavernous malformations following adjuvant gamma knife radiosurgery for mesial temporal lobe epilepsy [3]

Stereotactic radiosurgery is currently recognized as a viable treatment option for patients with intractable epilepsy as an alternative to conventional epilepsy surgery. Although the effectiveness of radiosurgical treatment for mesial temporal lobe epilepsy (MTLE) has been established, the long-term safety of this treatment has not been fully assessed.
They reviewed 20 patients with MTLE who underwent Gamma Knife radiosurgery (GKRS). The majority received a prescribed isodose of 24 Gy as an adjuvant treatment after anterior temporal lobectomy. During a median clinical followup of 14.0 years, delayed radiation-induced changes were identified in eight patients, including six cases of radiation necrosis and two cases of tumefactive cyst formation. Three cases were diagnosed with radiation-induced cavernous malformation (RICM).
Considering the propensity for repetitive hemorrhage and high epileptogenic potential, the development of RICM could be one of the most troublesome late sequelae following radiosurgery [2]. From this perspective, it is crucial to recognize that RICM should be considered as a potential late complication of radiosurgery, emphasizing the need for long-term imaging follow-up after the treatment.
It is to be pointed out that the development of RICM is not uncommon among patients who have received GKRS for MTLE. Practitioners should be aware of its potential as a long-term complication. Microsurgical resection of cavernous malformation has shown to be effective in enhancing seizure outcomes, particularly in cases where the initial results after GKRS are unsatisfactory.

Notes

Conflicts of interest

No other potential conflict of interest relevant to this article was reported.

Author contributions

Conceptualization : HJY; Data curation : HJY; Formal analysis : HJY; Methodology : HJY; Visualization : HJY; Writing - original draft : HJY; Writing - review & editing : HJY

Data sharing

None

Preprint

None

References

1. Compher C, Bingham AL, McCall M, Patel J, Rice TW, Braunschweig C, et al : Guidelines for the provision of nutrition support therapy in the adult critically ill patient: the American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr 46 : 12-41, 2022
crossref pmid pdf
2. Gross BA, Lin N, Du R, Day AL : The natural history of intracranial cavernous malformations. Neurosurg Focus 30 : E24, 2011
crossref pmid
3. Kim J, Byun J, Lee DH, Hong SH : A potential risk of radiation-induced cavernous malformations following adjuvant gamma knife radiosurgery for mesial temporal lobe epilepsy. J Korean Neurosurg Soc 67 : 458-466, 2024
crossref pdf
4. Kim J, Shim Y, Choo YH, Kim HS, Kim YR, Ha EJ : Protein requirement changes according to the treatment application in neurocritical patients. J Korean Neurosurg Soc 67 : 451-457, 2024
crossref pdf
TOOLS
PDF Links  PDF Links
PubReader  PubReader
ePub Link  ePub Link
XML Download  XML Download
Full text via DOI  Full text via DOI
Download Citation  Download Citation
  Print
Share:      
METRICS
0
Crossref
0
Scopus
724
View
31
Download
Related articles
Editors’ Pick in May 2024  2024 May;67(3)
Editors’ Pick in March 2024  2024 March;67(2)
Editors’ Pick in January 2024  2024 January;67(1)
Editors’ Pick in November 2023  2023 November;66(6)
Editors’ Pick in September 2023  2023 September;66(5)
Editorial Office
1F, 18, Heolleung-ro 569-gil, Gangnam-gu, Seoul, Republic of Korea
TEL: +82-2-525-7552   FAX: +82-2-525-7554   E-mail: office@jkns.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Neurosurgical Society.                 Developed in M2PI
Close layer